leadf
logo-loader
viewInnoCan Pharma
(
CSE:INNO
)

Innocan Pharma says Relief & Go CBD spray delivered pain relief to 90% of participants in clinical study

After 20 minutes, 83% of participants noticed improvement, the company said, which jumped to 95% after an hour

InnoCan Pharma Relief & Go packaging
Innocan's pain relief formulation contains a combination of magnesium oil, methyl salicylate, menthol and CBD, administered with a simple dose of spray, roll-on or lotion

Innocan Pharma Corporation (CSE:INNO) announced Monday that 90% of participants in a clinical study of the company’s Relief & Go over-the-counter (OTC) spray experienced a reduction in pain 24 hours after use.

The study, conducted by the Center for Podiatric Care & Sports Medicine in New York, included 18 people with pain ranging in area from the upper back to the feet.

After 20 minutes, 83% of participants noticed improvement, the company said, which jumped to 95% after an hour. After a full 24 hours, 90% described relief from pain.

READ: Innocan Pharma's cosmetic clinical study indicates 90% wrinkle reduction in volunteers using SHIR Premium CBD Facial Serum

Fifteen of the 18 participants would recommend the spray, the company said.

"We are thrilled that our clinical test yielded such promising results," CEO Iris Bincovich said in a statement. "Our unique approach and deep experience is exemplified in these impressive results that I'm certain are only the beginning."

The test was run by Joself Geldwert, who has more than 40 years of experience in foot surgery, biomechanics and sports injuries. He also serves on Innocan’s scientific advisory committee. 

"I have been following up with patients who I have been seeing for foot and ankle related problems that have been using Relief & Go pain relief spray, and their responses have been positive,” Geldwert said. “I am impressed by how well patients have been doing with a non-prescriptive OTC pain relief spray."

Innocan's pain relief formulation contains a combination of magnesium oil, methyl salicylate, menthol and CBD, administered with a simple dose of spray, roll-on or lotion. Relief & Go spray is designed to target pain-related muscle and provide relief for joint pain. 

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Quick facts: InnoCan Pharma

Follow
CSE:INNO

Price: 1.21 CAD

Market Cap: $267.96 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

CBD Science looks to raise £2M in Series A to advance its plant-based...

CBD Science Group PLC CEO Dr Michael Raymont joined Proactive New York to discuss the London, England-based group's Series A funding round, on the Crowd for Angels platform. Raymont says the privately-held company, which is developing plant-based cannabinoid pharmaceutical therapeutics to...

10 hours, 28 minutes ago

2 min read